1. Home
  2. TUYA vs QURE Comparison

TUYA vs QURE Comparison

Compare TUYA & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.31

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$17.14

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
QURE
Founded
2014
1998
Country
China
Netherlands
Employees
N/A
248
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
TUYA
QURE
Price
$2.31
$17.14
Analyst Decision
Strong Buy
Buy
Analyst Count
1
14
Target Price
$3.49
$44.92
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
05-19-2026
05-08-2026
Dividend Yield
5.19%
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$13.76
$126.12
Revenue Next Year
$11.90
$200.43
P/E Ratio
$27.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$8.19
52 Week High
$2.95
$71.50

Technical Indicators

Market Signals
Indicator
TUYA
QURE
Relative Strength Index (RSI) 46.28 51.01
Support Level $2.24 $13.52
Resistance Level $2.46 $18.37
Average True Range (ATR) 0.10 1.28
MACD -0.01 0.47
Stochastic Oscillator 33.33 83.12

Price Performance

Historical Comparison
TUYA
QURE

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: